Gene · 406940
Papers4,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metastatic Castration-Resistant Prostate Cancer: Insights on Current Therapy and Promising Experimental Drugs. | Res Rep Urol | 2023 | 37396015 | PubTator, text mining | PubMed |
| A comprehensive insight into the correlation between ncRNAs and the Wnt/β-catenin signalling pathway in gastric cancer pathogenesis. | Cell Commun Signal | 2023 | 37386429 | PubTator, text mining | PubMed |
| Helicobacter pylori plays a key role in gastric adenocarcinoma induced by spasmolytic polypeptide-expressing metaplasia. | World J Clin Cases | 2023 | 37383139 | PubTator, text mining | PubMed |
| Plant-Derived Nutraceuticals Involved in Body Weight Control by Modulating Gene Expression. | Plants (Basel) | 2023 | 37375898 | PubTator, text mining | PubMed |
| Can Dietary Actives Affect miRNAs and Alter the Course or Prevent Colorectal Cancer? | Int J Mol Sci | 2023 | 37373289 | PubTator, text mining | PubMed |
| The Potential Role of Epigenetic Modifications on Different Facets in the Periodontal Pathogenesis. | Genes (Basel) | 2023 | 37372382 | PubTator, text mining | PubMed |
| Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion. | Biomedicines | 2023 | 37371856 | PubTator, text mining | PubMed |
| A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma. | Cells | 2023 | 37371047 | PubTator, text mining | PubMed |
| Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms. | Cancers (Basel) | 2023 | 37370750 | PubTator, text mining | PubMed |
| Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics. | Cancer Metastasis Rev | 2023 | 37369946 | PubTator, text mining | PubMed |
| Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial. | Diabetes Metab J | 2023 | 37349083 | PubTator, text mining | PubMed |
| Advances in Therapeutic Applications of Extracellular Vesicles. | Int J Nanomedicine | 2023 | 37346366 | PubTator, text mining | PubMed |
| Crosstalk between Thyroid Carcinoma and Tumor-Correlated Immune Cells in the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37345200 | PubTator, text mining | PubMed |
| Effects of Co-Culture EBV-miR-BART1-3p on Proliferation and Invasion of Gastric Cancer Cells Based on Exosomes. | Cancers (Basel) | 2023 | 37345178 | PubTator, text mining | PubMed |
| The Effect of miR-4800 Restoration on Proliferation and Migration of Human Breast Cancer Cells In Vitro. | Adv Pharm Bull | 2023 | 37342379 | PubTator, text mining | PubMed |
| DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility. | NAR Cancer | 2023 | 37333613 | PubTator, text mining | PubMed |
| A Review of micro RNAs changes in T2DM in animals and humans. | J Diabetes | 2023 | 37329278 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway. | J Nanobiotechnology | 2023 | 37328872 | PubTator, text mining | PubMed |
| A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study. | Respir Res | 2023 | 37328754 | PubTator, text mining | PubMed |
| A plasmatic score using a miRNA signature and CXCL-10 for accurate prediction and diagnosis of liver allograft rejection. | Front Immunol | 2023 | 37325660 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406940/papers?page=17